ANGPTL4 and coronary artery disorder: Changes in ANGPTL4 protein levels via ANGPTL4 p.E40 K were associated with a decreased risk of CAD (OR 0.57, P = 1 × 10−19) and T2D (OR 0.73, P = 0.001) (Figure 2A).